Previous studies have shown activation of GPCR91 in DR and hypoxic retinal diseases, with the consequent activation of VEGF pathways and breakdown of the blood–retinal barrier (54, 55), which is one of the molecular features of DR. The gene discussed is VEGFA; the disease is Abnormal retinal morphology.